<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004818'>Paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) is an acquired clonal disorder characterized by a decrease or absence of <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi> (GPI)-anchored molecules such as CD55 and CD59 from the surface of affected cells, resulting in intravascular <z:mp ids='MP_0010163'>hemolysis</z:mp>, cytopenia, and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-like phenotype has been detected in various <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e>, mainly in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, but also in lymphoproliferative syndromes (LPSs) </plain></SENT>
<SENT sid="2" pm="."><plain>To the best of our knowledge, CD55- or CD59-deficient red cells have not been detected in <z:e sem="disease" ids="C1136084" disease_type="Neoplastic Process" abbrv="">plasma cell dyscrasias</z:e> (PCDs) </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was the detection of CD55- and/or CD59-deficient red cell populations in patients with PCD </plain></SENT>
<SENT sid="4" pm="."><plain>Seventy-seven patients were evaluated; 62 with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM), 7 with <z:hpo ids='HP_0005508'>Waldenstrom macroglobulinemia</z:hpo> (WM), 6 with <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of undetermined significance</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e>), and 2 with <z:e sem="disease" ids="C0018852" disease_type="Disease or Syndrome" abbrv="">heavy chain disease</z:e> (HCD) </plain></SENT>
<SENT sid="5" pm="."><plain>The sephacryl gel microtyping system was applied; Ham and <z:chebi fb="27" ids="17992">sucrose</z:chebi> lysis tests were also performed on <z:hpo ids='HP_0000001'>all</z:hpo> samples with CD55- or CD59-negative populations </plain></SENT>
<SENT sid="6" pm="."><plain>Red cells deficient in both molecules were detected in 10 (12.9%) of 77 patients with PCD: 2 (28.6%) of 7 with WM, 1 (16.6%) of 6 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e>, 6 (9.6%) of 62 with MM, and 1 of 2 patients with HCD </plain></SENT>
<SENT sid="7" pm="."><plain>Isolated CD55 deficiency was found in 28.5% of <z:hpo ids='HP_0000001'>all</z:hpo> PCD patients, whereas isolated CD59 deficiency was not observed in any patients </plain></SENT>
<SENT sid="8" pm="."><plain>These findings illustrate the existence of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> phenotype in the red cells of patients with PCD; further investigation is needed into the mechanisms and significance of this phenotype </plain></SENT>
</text></document>